Glanzmann thrombasthenia (GT) is an autosomal dominant coagulation disorder that results in spontaneous, prolonged, or heavy bleeding that can be life-threatening. It is caused by mutations in the ITGA2B or ITGB3 gene that result in defective or deficient platelet alpha IIb beta 3 integrin (formerly known as glycoprotein llb/llla), which is the platelet fibrinogen receptor. The functionality of this receptor is necessary for platelet aggregation. Acquired GT, on the other hand, is due to autoantibodies against alpha IIb beta 3 integrin.
Signs and symptoms include manifestations of mucocutaneous bleeding such as epistaxis, menorrhagia, petechiae, easy bruising, hematoma, and rarely intracranial hemorrhage or hematuria. Family history of bleeding is common.
Glanzmann thrombasthenia
Alerts and Notices
Important News & Links
Synopsis
Codes
ICD10CM:
D69.1 – Qualitative platelet defects
SNOMEDCT:
32942005 – Glanzmann Thrombasthenia
D69.1 – Qualitative platelet defects
SNOMEDCT:
32942005 – Glanzmann Thrombasthenia
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Reviewed:02/01/2021
Last Updated:01/16/2022
Last Updated:01/16/2022
Glanzmann thrombasthenia